TruTechnologies Secures Significant Growth Investment From LLR Partners
Article content
DURHAM, N.C. — LLR Partners today announced a strategic growth investment in TruTechnologies ™, a leading provider of real-time clinical trial oversight. LLR's growth capital and value creation resources will be dedicated to helping TruTechnologies' expansion as it transforms how pharmaceutical companies, together with clinical research organizations and research sites, oversee, monitor and manage biological samples and study workflows throughout the clinical trial lifecycle.
Article content
Article content
TruTechnologies aims to enhance workflow efficiency for research sites while enabling real-time visibility and interventions for pharmaceutical companies and clinical research organizations. Its flagship solution, TruLab ®, is a first-of-its-kind mobile-enabled offering for protocol-driven clinical trial oversight, biological sample management and tracking and risk-based monitoring.
Article content
'TruTechnologies was founded to solve the ongoing pain point in clinical research of managing biological samples with accuracy, efficiency and compliance,' said Scott Ogle, Co-Founder and CEO of TruTechnologies. 'LLR understands our mission, our customers and our industry. We are excited to partner with LLR as we scale to deliver more value to pharmaceutical companies, clinical research organizations and research sites around the world.'
Article content
Building on TruLab, TruTechnologies has launched two complementary solutions: TruDose ™, which provides dosing compliance and deviation monitoring, and TruScreen ™, which enables real-time visibility to trial participant screening visits and associated outcomes.
Article content
'After 25 years in drug development, I've seen firsthand how lack of visibility into study conduct significantly impacts clinical trial outcomes,' said Rick Graham, PhD, Co-Founder and Chairman of TruTechnologies. 'That's why I'm so proud of what we've built – a solution that finally brings transparency, accountability and oversight to one of the most overlooked aspects of clinical trial execution.'
Article content
LLR's investment in TruTechnologies builds on its history of partnering with companies driving efficiency and innovation across life sciences and healthcare.
Article content
'TruTechnologies has pioneered a differentiated solution in a critical but historically underserved area of clinical trials,' said Zack Sigal, Partner at LLR Partners. William Sadock, Vice President at LLR Partners, added, 'The market TruTechnologies serves is driven by the increasing complexity of clinical trials and demand for more precise, real-time oversight and interventions across the research ecosystem. We are excited to partner with TruTechnologies as they continue to support more clinical teams with real-time insights.'
Article content
BofA Securities, Inc. served as the exclusive financial advisor to TruTechnologies in this transaction. Wachtell, Lipton, Rosen & Katz served as legal advisor to TruTechnologies. DLA Piper served as legal advisor to LLR Partners.
Article content
About TruTechnologies
Founded in 2018, TruTechnologies is the leading provider of real-time clinical trial oversight, focused on enabling timely, high-quality data and mitigating risks in drug development. The company partners with six top 20 pharmaceutical companies and numerous biotechnology firms to accelerate patient screening and enrollment, drive protocol adherence, and correct deviations. Learn more at TruTechnologies.io and follow on LinkedIn.
Article content
About LLR Partners
LLR Partners is a lower middle market private equity firm investing in technology and healthcare businesses. We collaborate with our portfolio companies to define high-impact growth initiatives, turn them into action and help create long-term value. Founded in 1999 and with more than $7 billion raised across seven funds, LLR is a flexible provider of equity capital for growth, recapitalization and buyouts. Learn more at www.llrpartners.com.
Article content
Article content
Article content
Article content
Article content
Contacts
Article content
Article content
Article content
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
7 hours ago
- Globe and Mail
Prediction: These 2 Stocks Could Beat the Market in the Next Decade
Those concerned about recent market volatility can take comfort in the fact that equity markets will likely deliver competitive returns over the next decade. Selling shares of top companies now may result in lower stock market gains than investors might have otherwise earned over the long term if they had held on. The better strategy is to stick to your holdings and be on the lookout for companies that can perform well, perhaps even better, than the market given enough time. Two stocks that might have what it takes are Roku (NASDAQ: ROKU) and MercadoLibre (NASDAQ: MELI). Here's more on these potential market beaters. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » 1. Roku Although Roku started 2025 strong, its shares have been in free fall for the past few weeks, partly due to somewhat disappointing financial results and guidance. Potential tariff-related headwinds are also not helping. Despite these concerns, the company's financial results remain strong, and its ecosystem continues to grow and strengthen. In the first quarter, Roku's revenue increased by 16% year over year to $1 billion. Streaming hours were 35.8 billion, 5.1 billion more than in the comparable period of the previous fiscal year. As more people spend more time on Roku's platform, the company's ecosystem becomes more valuable to advertisers, a classic example of the network effect. During the first period, Roku's platform revenue, which includes ad-related sales, increased by 17% year over year, compared to 11% year-over-year growth for its device segment, where it reports sales of its namesake streaming devices. Roku remains unprofitable, but it also made some progress on this front in the quarter, reporting a net loss per share of $0.19, which is better than the $0.35 reported in Q1 2024. Roku could feel some volatility in the near term, and the impact of tariffs remains somewhat uncertain. However, Roku has sold its devices at a loss before when faced with the choice. The company prioritizes deepening engagement within its ecosystem -- that's where the long-term opportunity lies. So, if tariffs lead to higher manufacturing costs for its devices, Roku will likely adopt the same strategy as before. Meanwhile, television viewing time is expected to continue shifting away from cable and toward streaming in the long run. And whichever giant in the industry wins the race makes little difference to Roku, which grants its users access to most of the big players in the streaming market. Advertising dollars will follow viewers wherever they go, providing Roku with plenty of revenue growth opportunities. Lastly, Roku's shares look reasonably valued. The company's forward price-to-sales ratio is just 2.3. The official undervalued range starts at 2, but the leader in the connected TV market in North America, even ahead of some tech giants, is worth the slight premium, in my view. Though the stock has dipped in the past few weeks, investors focused on the long game should seriously consider picking up the company's shares and holding on to them for the next decade. 2. MercadoLibre MercadoLibre is the undisputed leader in e-commerce in Latin America. The company has successfully fended off competition from local players and international powerhouses, including Amazon. But MercadoLibre isn't just an e-commerce platform -- it provides a comprehensive suite of services to merchants. The company's fintech platform also looks promising. MercadoLibre's dominance in these markets is leading to strong performances and financial results. The stock has increased by 48% this year. In the first quarter, the company's net revenue increased by 37% year over year to $5.9 billion. MercadoLibre's net income came in at $494 million, up 43.6% compared to the year-ago period. Other important metrics trended up, including gross merchandise volume, fintech monthly active users, and more. Those are the kinds of performances investors are used to with MercadoLibre. It arguably justified its forward price-to-earnings (P/E) ratio of 52.2, nearly twice the 27.9 average for the consumer discretionary sector. Here's the flip side: If MercadoLibre fails to perform in line with market expectations, its shares will drop significantly. Furthermore, although it does business in Latin America and won't suffer directly from the impact of tariffs, general economic instability that could result from President Donald Trump's trade policies would still have an impact on the stock. These are all legitimate concerns, but long-term investors should still consider buying the stock. There is massive whitespace in the e-commerce market in Latin America. Nobody is better positioned to benefit from it. MercadoLibre's revenue and profits should grow rapidly in the next 10 years. Even if the stock experiences a correction due to its valuation, in the long run, it should still outperform the market, just as it has in the past, despite some volatility and steep valuation metrics. MercadoLibre remains a strong candidate to outperform the market through 2035. Should you invest $1,000 in Roku right now? Before you buy stock in Roku, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Roku wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $669,517!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $868,615!* Now, it's worth noting Stock Advisor 's total average return is792% — a market-crushing outperformance compared to171%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of June 2, 2025
CTV News
7 hours ago
- CTV News
Alberta resumes U.S. liquor imports
Alberta resumes U.S. liquor imports As CTV Calgary's Tyler Barrow reports, Alberta says it is ready for a renewed trade agreement with the U.S.
CTV News
7 hours ago
- CTV News
Are U.S. tourism efforts to win back Canadian travellers falling flat?
Watch Efforts to lure Canadians to the U.S. may be falling flat as travel to the U.S. fell nearly 13 per cent while travel to non-U.S. destinations rose 19 per cent.
